Autori: Ramalingam Suresh S
| Naslov | Randomized Phase III Study of Ganetespib, a Heat Shock Protein 90 Inhibitor, With Docetaxel Versus Docetaxel in Advanced Non?Small-Cell Lung Cancer (GALAXY-2) (Article) |
| Autori | Pillai Rathi N Fennell Dean A Kovcin Vladimir N Ciuleanu Tudor E Ramlau Rodryg Kowalski Dariusz Schenker Michael Yalcin Ilker Teofilovici Florentina Vukovic Vojo M Ramalingam Suresh S |
| Info | JOURNAL OF CLINICAL ONCOLOGY, (2020), vol. 38 br. 6, str. 613-+ |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
     |
| Naslov | Phase 3 Study of Ganetespib, a Heat Shock Protein 90 Inhibitor, with Docetaxel versus Docetaxel in Advanced Non-Small Cell Lung Cancer (GALAXY-2) (Meeting Abstract) |
| Autori | Pillai Rathi N Fennell Dean Kovcin Vladimir N Ciuleanu Tudor E Ramlau Rodryg Kowalski Dariusz Schenker Michael Perin Branislav M Yalcin Ilker Teofilovici Florentina Vukovic Vojo M Ramalingam Suresh S |
| Info | JOURNAL OF THORACIC ONCOLOGY, (2017), vol. 12 br. 1, Suppl. S, str. S7-S8 |
| Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science Scopus |
|
|
| Naslov | A randomized phase II study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel in second-line therapy of advanced non-small cell lung cancer (GALAXY-1) (Article) |
| Autori | Ramalingam Suresh S ... Zaric Bojan  Andric Zoran G ... (broj koautora 22)
|
| Info | ANNALS OF ONCOLOGY, (2015), vol. 26 br. 8, str. 1741-1748 |
| Projekat | Synta Pharmaceuticals Corporation |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
|
|
| Naslov | Galaxy-2 trial (NCT01798485): A randomized phase 3 study of ganetespib itt combination with docetaxel versus docetaxel alone in patients with advanced lung adenocarcinoma. (Meeting Abstract) |
| Autori | Ramalingam Suresh S Zaric Bojan Ceric Timur ... Samarzija Miroslav ... Vukovic Vojislav M (broj koautora 20)
|
| Info | JOURNAL OF CLINICAL ONCOLOGY, (2014), vol. 32 br. 15, Suppl. S, str. - |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
|
|
| Naslov | Galaxy-1: Randomized Phase Ii Study of Docetaxel with Or Without Ganetespib in Advanced Lung Adenocarcinoma: Results in Biomarker Sub-Groups and All Adenocarcinoma Patients. (Meeting Abstract) |
| Autori | Ramalingam Suresh S ... Zaric Bojan ... Andric Zoran G ... (broj koautora 26)
|
| Info | JOURNAL OF THORACIC ONCOLOGY, (2013), vol. 8 br. , Suppl. 2, str. S139-S139 |
| Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
|
| Naslov | A randomized study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel versus docetaxel alone for second-line therapy of lung adenocarcinoma (GALAXY-1). (Meeting Abstract) |
| Autori | Ramalingam Suresh S ... Andric Zoran G ... Zaric Bojan ... Vukovic Vojislav M ... (broj koautora 20)
|
| Info | JOURNAL OF CLINICAL ONCOLOGY, (2013), vol. 31 br. 18, Suppl. S, str. - |
| Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
|
| Naslov | A randomized study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel versus docetaxel alone for second-line therapy of lung adenocarcinoma (GALAXY-1) (Meeting Abstract) |
| Autori | Ramalingam Suresh S ... Andric Zoran G ... Zaric Bojan Ceric Timur ... Vukovic Vojislav M ... (broj koautora 20)
|
| Info | JOURNAL OF CLINICAL ONCOLOGY, (2013), vol. 31 br. 15, Suppl. S, str. - |
| Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
|
| Naslov | Ganetespib in combination with docetaxel versus docetaxel alone in second line adenocarcinoma patients with KRAS mutations and elevated LDH levels (Meeting Abstract) |
| Autori | Fennell DA Goss GD Andric Zoran G Bondarenko Igor N Zaric Bojan Ceric Timur Poddubskaya Elena Teofilovici F Guo W Ramalingam Suresh S
|
| Info | EUROPEAN JOURNAL OF CANCER, (2013), vol. 49 br. , Suppl. 2, str. S801-S801 |
| Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
|
